41 studies found for:    " May 28, 2008":" June 27, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Durability of Nevirapine-Based Antiretroviral Regimen
Condition: HIV Infections
Intervention: Drug: nevirapine
22 Completed Effectiveness of an HIV Prevention Program That Targets the Inner Workings of High-risk Social Networks
Condition: HIV Infections
Interventions: Behavioral: Network leader training;   Behavioral: Standard HIV risk-reduction counseling
23 Active, not recruiting Effectiveness of Communication Technology in Disseminating HIV Prevention Training to Non-governmental Organizations
Condition: HIV Infections
Interventions: Behavioral: Face-to-face training;   Behavioral: Distance training;   Behavioral: Popular Opinion Leader (POL)
24 Completed VENICE Study Nevirapine Full Dose/Dose Escalation
Condition: HIV Infections
Intervention: Drug: nevirapine
25 Completed Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Emtricitabine/tenofovir disoproxil fumarate placebo;   Drug: Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate placebo;   Drug: Tenofovir 1% vaginal gel;   Drug: Tenofovir placebo
26 Unknown  The Detection of Drug-Resistant HIV-1 in Taiwan
Condition: HIV Infections
Intervention:
27 Completed
Has Results
Kaletra-isentress Treatment Evaluation
Condition: HIV Infections
Interventions: Drug: Kaletra + Isentress;   Drug: Pre-study antiretroviral regimen
28 Unknown  Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection
Conditions: Latent Tuberculosis Infection;   HIV Infections;   Tuberculosis
Intervention:
29 Completed Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations
Conditions: HIV Infections;   Malaria
Interventions: Drug: lopinavir/ritonavir;   Drug: efavirenz;   Drug: artemether/lumefantrine
30 Completed Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)
Condition: HIV Infections
Interventions: Drug: Vicriviroc maleate;   Drug: Placebo;   Drug: Emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg
31 Withdrawn Observational Study of Antiretroviral (ARV) Response in a Cohort of African Children Using Viral Load Monitoring
Condition: HIV Infection
Intervention:
32 Completed Trial of Cognitive Behavioral Therapy to Reduce Antiretroviral Therapy Side Effects
Conditions: HIV Infections;   Adverse Effects
Intervention: Behavioral: Cognitive-behavioral therapy
33 Completed
Has Results
Immune Responses to Pneumococcal Vaccination Among HIV-infected Subjects
Condition: HIV Infections
Interventions: Biological: (PV) 23-valent pneumococcal polysaccharide vaccine;   Biological: Placebo
34 Withdrawn Surveillance Cohort Long-Term Toxicity Antiretrovirals in HIV-Infected Patients Enrolled in TPV Cohort
Condition: HIV Infections
Intervention: Drug: Tipranavir
35 Completed Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc
Condition: HIV Infections
Intervention: Drug: Maraviroc
36 Recruiting Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
Conditions: Aids-related Malignancies;   Lymphoma;   Precancerous Condition;   Sarcoma
Interventions: Genetic: polymerase chain reaction;   Other: cytology specimen collection procedure;   Other: histological technique;   Procedure: colposcopic biopsy
37 Completed Linkage to Care - Part I
Condition: HIV
Intervention:
38 Completed Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.
Condition: Tuberculosis (TB)
Interventions: Biological: GSK's candidate Mycobacterium tuberculosis vaccine 692342;   Biological: Control vaccine with the adjuvant system.;   Biological: Control vaccine with physiological saline
39 Unknown  TDM of Generic Lopinavir/Ritonavir 200/50 mg
Condition: HIV
Intervention: Drug: generic lopinavir/ritonavir
40 Completed Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients
Condition: Hepatitis C
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-41) Show next page of results
Indicates status has not been verified in more than two years